Rouven Bingel-Erlenmeyer

Rouven Bingel-Erlenmeyer is the Chief Technical Development Officer at CDR-Life. Previously, Rouven was Global Lead Drug Substance Development Office Scientific Standards & Integration at Novartis.

Rouven earned a Ph.D. in Structural Biology, Protein Chemistry, Biophysics from ETH Zürich in 2007.